Wordt geladen...
Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors
Tyrosine kinase inhibitors such as imatinib mesylate have changed the clinical course of chronic myeloid leukemia; however, the observation that these inhibitors do not target the leukemia stem cell implies that patients need to maintain lifelong therapy. The mechanism of this phenomenon is unclear:...
Bewaard in:
Hoofdauteur: | |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
AlphaMed Press
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973707/ https://ncbi.nlm.nih.gov/pubmed/24598782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2012-0159 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|